Matthew Moore
Director de Operaciones en VENTYX BIOSCIENCES, INC. .
Fortuna: 1 M $ al 31/05/2024
Perfil
Matthew Moore is currently the Chief Operating Officer at Ventyx Biosciences, Inc. He previously held the position of Vice President-Corporate Business Development at Allergan Ltd.
(Ireland) from 2015 to 2020.
Prior to that, he served as the Chief Business Officer & Senior Vice President at Arcutis Biotherapeutics, Inc. from 2021 to 2024.
Mr. Moore completed his undergraduate degree at Trinity College.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 02/05/2024 | 145 505 ( 0.13% ) | 1 M $ | 31/05/2024 | |
VENTYX BIOSCIENCES, INC.
-.--% | 16/05/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Cargos activos de Matthew Moore
| Empresas | Cargo | Inicio |
|---|---|---|
| VENTYX BIOSCIENCES, INC. | Director de Operaciones | 16/05/2024 |
Antiguos cargos conocidos de Matthew Moore.
| Empresas | Cargo | Fin |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01/05/2024 |
| ALLERGAN PLC | Corporate Officer/Principal | 01/01/2020 |
Formación de Matthew Moore.
| Trinity College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
| VENTYX BIOSCIENCES, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
- Bolsa de valores
- Insiders
- Matthew Moore
